Skip to main content
Log in

Stellenwert der Strahlentherapie von Residualtumoren nach Chemotherapie metastasierter Seminome

  • Literatur Kommentiert
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Bamberg M, Schmoll H-J, Weißbach L, et al. Interdisziplinäre Konsensuskonferenz zur „Diagnostik und Therapie von Hodentumoren”. Strahlenther Onkol 1997;173:397–406.

    Article  PubMed  CAS  Google Scholar 

  2. Duchesne GM, Stenning SP, Aass N, et al. Radiotherapy after chemotherapy for metastatic seminoma — a diminishing pole. Eur J Cancer 1997;33:829–35.

    Article  PubMed  CAS  Google Scholar 

  3. MacVicar D, Horwich A. Sites of relapse in seminoma treated with single agent carboplatin chemotherapy: Implications for further management. Clin Oncol 1992;4:209–13.

    Article  CAS  Google Scholar 

  4. Puc H, Heelan R, Mazumdar M, et al. Management of residual mass in advanced seminoma: Results and recommendations from the Memorial Sloan-Kettering Center. J Clin Oncol 1996;14:454–60.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bamberg, M., Claßen, J. Stellenwert der Strahlentherapie von Residualtumoren nach Chemotherapie metastasierter Seminome. Strahlenther Onkol 174, 442–443 (1998). https://doi.org/10.1007/BF03038572

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03038572

Navigation